Australian Hepatitis and Risk Survey in Prisons
试验速览
- 阶段
- 不适用
- 状态
- 招募中
- 入组人数
- 2,400
- 试验地点
- 24
- 主要终点
- The prevalence of HCV in Australian prisons
研究概览
简要总结
The Australian Hepatitis and risk survey in prisons (AusHep) is a national prison-based blood-borne virus (BBV) surveillance study. This biobehavioural survey involves point-of-care testing for hepatitis C (HCV) antibodies and RNA (if antibody positive), hepatitis B surface antigens, hepatitis B surface antibodies, and HIV surface antibodies, and an interview-style survey on prior testing and treatment history and engagement in risk behaviours. The study will recruit approximately 2400 prisoner participants from 25 representative prisons across Australia, annually.
研究设计
- 研究类型
- Observational
- 观察模型
- Case Only
- 时间视角
- Prospective
入排标准
- 年龄范围
- 18 Years 至 —（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 是
入选标准
- •Any remandee or sentenced prisoner who has provided informed consent is eligible to participate in the study.
排除标准
- •Individuals who are unable or unwilling to provide consent or abide by the requirements of the study, as assessed by the trained nurses. Some individuals may be considered unable to provide consent or abide by the requirements of the study if they are:
- •Too mentally unwell to provide consent
- •Profoundly intellectually impaired
- •Unable to speak English and comprehend the survey.
- •Those excluded from participating in the study will be referred to the local prison clinic service for standard of care.
结局指标
主要结局
The prevalence of HCV in Australian prisons
时间窗: 1 Year
This is estiamted by perfroming the HCV antibody test and HCV RNA viral load test on a representative prison population.
The prevalance of HBV in Australian prisons
时间窗: 1 year
This is estimated by performing the HBV surface antigen test on a respresentative prison population
The prevalance of HIV in Australian prisons
时间窗: 1 year
This is estimated by performing the HIV antibody test on a respresentative prison population.
次要结局
- The factors associated with HCV and HBV infection investigated by the bio-behavioural survey.(1 Year)
- The proportion of individuals who are engaged in each step of HBV and HCV care cascades(1 Year)
- The prevalence of risk behaviours and harm reduction access(1 Year)
- The factors associated with engaging in each step of HCV and HBV care cascades and HBV vaccination investigated by the bio-behavioural survey.(1 Year)